A drug-inducible CRISPR/Cas9 system for gene transcriptional activation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- INST OF ZOOLOGY CHINESE ACAD OF SCI
- Publication Date
- 2020-12-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the field of molecular biology, in particular to a drug-inducible CRISPR / Cas9 system for gene transcription activation. Background technique
[0002] CRISPR / Cas9 system, derived from the immune mechanism of bacteria to degrade invading viral DNA or other foreign DNA. Using RNA-mediated DNA-binding and endonuclease activities, this system can be regulated in the genome in a sequence-dependent manner. Cas9 protein binds and cleaves double-stranded DNA in a sequence-specific manner, and this sequence-specific binding is achieved through a guide RNA (gRNA) complementary to the target sequence and the adjacent protospacer-adjacent motif (PAM). The complex formed by Cas9 and gRNA mediates DNA double-strand breaks, and also completes targeted gene editing through two DNA repair mechanisms, NHEJ and HDR. The CRISPR / Cas9 system can also be combined with different effector molecules to expand its functions, enabling transcripti...